TENAX THERAPEUTICS, INC. (TENX) Operating cash flow 2016–2025
TENAX THERAPEUTICS, INC. (TENX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35.8MFY2025 · since FY2016: -$15.9M → -$35.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.8M | -141.7% |
| FY2024 | -$14.8M | -150.9% |
| FY2023 | -$5.9M | +48.2% |
| FY2022 | -$11.4M | -4.9% |
| FY2021 | -$10.9M | -17.1% |
| FY2020 | -$9.3M | -22.7% |
| FY2019 | -$7.6M | -37.4% |
| FY2018 | -$5.5M | +54.7% |
| FY2017 | -$12.1M | +23.5% |
| FY2016 | -$15.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TENX financial trends
TENX RevenueTENX Net incomeTENX Net marginTENX Gross profitTENX Gross marginTENX Operating incomeTENX Operating marginTENX Free cash flowTENX Capital expendituresTENX Return on equityTENX Stock buybacksTENX Dividends paidTENX Total assetsTENX Total liabilitiesTENX Shareholders’ equityTENX overview →